The effect of basic carbohydrate counting on HbA1c in type 2 diabetic patients: A non-randomized controlled trial.

Aim: To evaluate the effect of basic carbohydrate counting (CC) on HbA1c in Type 2 Diabetes (T2D) patients using oral antidiabetic drugs in the primary care.

Method: The study is a non-randomized controlled clinical trial. T2D patients, aged between 18 and 75 years, HbA1c ≥ 6,5 %, using oral antidiabetic medication, were followed for three months in two groups: one intervention (IG) (n = 33), one control group (CG) (n = 45), in two different Primary Care Centers.